Disclosure: The Iron Verdict may earn commissions from qualifying purchases at no extra cost to you. Learn more ->

Fatigue On GLP-1 Medications: Why It Happens

Tiredness on these medications is real, measurable in the trials, and usually has nothing to do with the drug acting on your energy systems. It has four causes, three of which are fixable — which is why lumping them together is the mistake.

Publication date: 2026-08-09Last updated: 2026-08-09Reading time: 7 minAuthor: The Iron Verdict Research Team

What You'll Learn

How CommonThe trial figure against placebo.
Cause 1You are simply eating less.
Cause 2Protein and micronutrients.
Cause 3Fluid and electrolytes.
Cause 4Poor sleep from GI symptoms.
When To WorryWhat is not ordinary fatigue.

Table of Contents

  1. How Common Is It?
  2. Cause 1: You Are Eating Considerably Less
  3. Cause 2: Protein And Micronutrients
  4. Cause 3: Fluid And Electrolytes
  5. Cause 4: You Are Sleeping Worse
  6. What Is Not Ordinary Fatigue
  7. FAQ
  8. Scientific references

How Common Is It?

Fatigue is a listed adverse event, and the trial data lets you put a number on it rather than guessing from forums.

Fatigue reported by 7.0% on tirzepatide against 3.1% on placeboPhase 3 RCT
SURMOUNT-3 — Nature Medicine, 2023

In 579 adults randomised after an intensive lifestyle intervention, additional mean weight change to week 72 was −18.4% with tirzepatide against +2.5% with placebo. Fatigue was reported by 20 participants (7.0%) on tirzepatide and 9 (3.1%) on placebo — raised, but far less common than gastrointestinal effects.

Full study on PMC ↗

Bottom line: Roughly double the placebo rate, but affecting about one person in fourteen — nowhere near the frequency of nausea, which around 44% report. Fatigue is a real effect that most people do not get.

Cause 1: You Are Eating Considerably Less

This is the largest cause and the least interesting, which is why it gets skipped over.

These medications work by reducing energy intake. A substantial caloric deficit produces tiredness in anyone, on any diet, with or without a drug involved. If you have gone from eating 2,400 calories to eating 1,300, feeling flat is the expected result, not a side effect that needs explaining.

What separates ordinary deficit fatigue from something worth investigating is the trajectory. Deficit fatigue is worst in the first weeks after each dose increase and settles as intake stabilises. Fatigue that deepens steadily over months is a different question.

Cause 2: Protein And Micronutrients

Eating less of everything means eating less of the things you need. Iron, vitamin B12, vitamin D and folate are the usual suspects behind fatigue, and all of them become harder to reach when total food volume drops.

Protein deserves particular attention here because it is the one that also drives the body-composition outcome:

Protein and resistance training named as the two prioritiesJoint clinical advisory
ACLM, ASN, OMA & The Obesity Society — American Journal of Clinical Nutrition, 2025

A joint advisory from four major U.S. nutrition and obesity societies sets a protein target of 1.2–1.6 g/kg body weight per day (or about 1.5 g/kg of lean body mass) during active weight loss, distributed at roughly 25–30 g per meal, and recommends structured resistance training alongside pharmacotherapy.

Read the advisory ↗

Bottom line: Losing muscle makes everything feel heavier — stairs, shopping, a training session. Some of what people experience as fatigue is strength quietly declining.

Cause 3: Fluid And Electrolytes

A large share of daily fluid arrives with food. Smaller meals mean less fluid, usually without anyone noticing the change, and mild dehydration presents as tiredness and headache long before thirst becomes obvious.

Add vomiting or diarrhoea and the losses become significant rather than marginal. This is not a hypothetical concern:

Kidney-injury signal, with dehydration named as the main pathwayPharmacovigilance analysis
Comparative Safety of GLP-1 Receptor Agonists Across Gastrointestinal, Renal and Pancreatic Systems — Pharmaceuticals, 2026

Analysing FDA adverse-event reports, semaglutide showed the strongest acute kidney injury signal (PRR 1.25, 95% CI 1.08–1.44), above liraglutide (0.86) and tirzepatide (0.34). The authors identify the pathway plainly: volume depletion from severe nausea, vomiting and diarrhoea is the main cause of GLP-1-associated AKI. Disproportionality analysis shows reporting patterns, not incidence.

Full text on PMC ↗

Important: If you have had a period of persistent vomiting or diarrhoea and then feel unusually weak, dizzy on standing, or notice you are passing much less urine, that combination needs medical assessment rather than more water at home.

Cause 4: You Are Sleeping Worse

This one is under-recognised. Reflux and nausea are among the most reported effects of this drug class, and both are worse lying down. Delayed gastric emptying means going to bed with food still in the stomach more often than before.

The result is fragmented sleep that people do not connect to the medication, because they remember the nausea and not the waking. If daytime tiredness is the complaint, how you are sleeping is worth auditing before anything else.

Practical: leave a longer gap between the last meal and bed. Our nausea guide covers the rest.

GI adverse events quantified across 106,395 trial participantsMeta-analysis of 55 RCTs
Systematic review and meta-analysis — Gastroenterology, 2025

Pooling 55 placebo-controlled randomised trials, GLP-1 receptor agonists increased cholelithiasis risk (RR 1.46, 95% CI 1.09–1.97) and probably increased GERD risk (RR 2.19, 95% CI 1.48–3.25). Gastrointestinal effects were the most frequently reported adverse events overall.

View study abstract ↗

What Is Not Ordinary Fatigue

Most fatigue here is explainable and improves as the four causes above are addressed. Some presentations are not:

  • Fatigue that worsens steadily rather than fluctuating with dose changes
  • Fatigue with breathlessness, palpitations or dizziness on standing
  • Fatigue alongside symptoms of low blood sugar, particularly if you also take insulin or a sulfonylurea
  • Fatigue severe enough to interfere with driving or work

Bloods for iron, B12, vitamin D and thyroid are the standard first step and a reasonable thing to ask for.

GLP-1 Full Guide
The book

GLP-1 Full Guide

Everything on this page, and the other 39 articles, in one 151-page book — plus a 30-day protocol, four weeks of meal plans and the tracker pages, none of which are on the site.

19 peer-reviewed references, cited by PMID and DOI. Where two studies disagree, both are shown.

See the book →

FAQ

How common is fatigue on GLP-1 medications?

In the SURMOUNT-3 trial, fatigue was reported by 7.0% of participants on tirzepatide against 3.1% on placebo — roughly double, but far less common than nausea, which around 44% report.

Why do I feel so tired on Ozempic or Wegovy?

Four causes stack: a substantial caloric deficit, lower protein and micronutrient intake, reduced fluid because much daily fluid arrives with meals, and fragmented sleep from reflux and nausea. Three of the four are fixable.

Does the fatigue go away?

Deficit-related fatigue is typically worst in the weeks after each dose increase and settles as intake stabilises. Fatigue that deepens steadily over months is a different question and worth investigating with bloods.

What should I get checked?

Iron and ferritin, vitamin B12, vitamin D and thyroid are the standard first checks for fatigue, and deficiency is more likely when total food intake falls.

Scientific References

  1. Wadden TA, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine, 2023. Full text on PMC.
  2. Comparative Safety of GLP-1 Receptor Agonists Across Gastrointestinal, Renal and Pancreatic Systems. Pharmaceuticals (Basel), 2026. Full text on PMC.
  3. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. American Journal of Clinical Nutrition, 2025. Read the advisory.

Medical Disclaimer

This article is educational and not medical advice, and does not recommend, endorse, or provide dosing guidance for any prescription medication. GLP-1 medications require a prescription and medical supervision. Talk to a qualified clinician before starting, stopping, or changing any medication.

The Iron Verdict

Get the evidence, not the hype

Free, independent breakdowns of GLP-1 research, supplement evidence and product picks — straight to your inbox. No spam, no paid rankings.

Free forever. Unsubscribe anytime. No spam, no paid rankings.